Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC

Clinical trial NCT06846450 · RECRUITING

Trial details

NCT number: NCT06846450
Sponsor: Lin Kong, MD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)

Start date: 2025-04-01
Primary completion: 2031-01-31
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.